All News Top News Oct 21, 2018 Teva and New Jersey Governor Murphy Formalize North America Headquarters Move with Ceremony in Israel Learn More Share Top News Oct 11, 2018 Teva Draws on Patient Experience to Empower Those Living with Chronic Conditions Learn More Share Top News Oct 10, 2018 Celltrion and Teva Announce FDA Oncologic Drugs Advisory Committee Recommends Approval of Celltrion BLA for CT-P10, a Proposed Rituximab Biosimilar Learn More Share Top News Oct 10, 2018 Teva Presents 25-year Safety Data from Longest Continuous Trial of COPAXONE® (glatiramer acetate injection) for the Treatment of Relapsing Forms of Multiple Sclerosis Learn More Share Top News Oct 8, 2018 Teva to Present New Data at 34th European Committee for Treatment and Research in Multiple Sclerosis Congress in Berlin Learn More Share
Top News Oct 21, 2018 Teva and New Jersey Governor Murphy Formalize North America Headquarters Move with Ceremony in Israel Learn More
Top News Oct 11, 2018 Teva Draws on Patient Experience to Empower Those Living with Chronic Conditions Learn More
Top News Oct 10, 2018 Celltrion and Teva Announce FDA Oncologic Drugs Advisory Committee Recommends Approval of Celltrion BLA for CT-P10, a Proposed Rituximab Biosimilar Learn More
Top News Oct 10, 2018 Teva Presents 25-year Safety Data from Longest Continuous Trial of COPAXONE® (glatiramer acetate injection) for the Treatment of Relapsing Forms of Multiple Sclerosis Learn More
Top News Oct 8, 2018 Teva to Present New Data at 34th European Committee for Treatment and Research in Multiple Sclerosis Congress in Berlin Learn More